TrialJectory

Business news, market intelligence, and global industry analysis.

The Latest

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026

Representative image: An oncologist collaborates with an AI system in a next-gen clinical trial center, reviewing patient eligibility data on-screen as precision oncology enters the era of intelligent matching.

Can AI trial matching close the gap in cancer drug access?

Can AI fix clinical trial access in cancer care? Discover how Tempus, TrialJectory, and CureMatch are using intelligent platforms to democratize treatment pathways.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

June 6, 2025